135 related articles for article (PubMed ID: 37917411)
1. Intracellular Complement (Complosome) is Expressed in Several Types of Human Adult Bone Marrow-Derived Stem Cells.
Bujko K; Brzenziakiewicz-Janus K; Kucia M; Ratajczak MZ
Stem Cell Rev Rep; 2024 Jan; 20(1):437-439. PubMed ID: 37917411
[No Abstract] [Full Text] [Related]
2. Complosome - the intracellular complement system.
West EE; Kemper C
Nat Rev Nephrol; 2023 Jul; 19(7):426-439. PubMed ID: 37055581
[TBL] [Abstract][Full Text] [Related]
3. Complement, complosome, and complotype: A perspective.
Singh P; Kemper C
Eur J Immunol; 2023 Dec; 53(12):e2250042. PubMed ID: 37120820
[TBL] [Abstract][Full Text] [Related]
4. A novel view of the adult bone marrow stem cell hierarchy and stem cell trafficking.
Ratajczak MZ
Leukemia; 2015 Apr; 29(4):776-82. PubMed ID: 25486871
[TBL] [Abstract][Full Text] [Related]
5. In vitro treatment of autologous bone marrow for neuroblastoma patients with anti GD2 monoclonal antibody and human complement: a pilot study.
Stein J; Strandjord S; Saarinen U; Warkentin P; Gerson S; Lazarus H; Von Hoff D; Coccia P; Cheung NK
Prog Clin Biol Res; 1988; 271():237-48. PubMed ID: 3043451
[No Abstract] [Full Text] [Related]
6. Selective cytotoxicity of murine monoclonal antibody LAM2 against human small-cell carcinoma in the presence of human complement: possible use for in vitro elimination of tumor cells from bone marrow.
Stahel RA; Mabry M; Sabbath K; Speak JA; Bernal SD
Int J Cancer; 1985 May; 35(5):587-92. PubMed ID: 2987136
[TBL] [Abstract][Full Text] [Related]
7. Aplastic anemia: presence in human bone marrow of cells that suppress myelopoiesis.
Kagan WA; Ascensão JA; Pahwa RN; Hansen JA; Goldstein G; Valera EB; Incefy GS; Moore MA; Good RA
Proc Natl Acad Sci U S A; 1976 Aug; 73(8):2890-4. PubMed ID: 1085449
[TBL] [Abstract][Full Text] [Related]
8. Intracellular complement - the complosome - in immune cell regulation.
Arbore G; Kemper C; Kolev M
Mol Immunol; 2017 Sep; 89():2-9. PubMed ID: 28601357
[TBL] [Abstract][Full Text] [Related]
9. Depletion of T cells from human bone marrow with monoclonal antibody CT-2 and complement.
Trigg ME; Billing R; Sondel PM; Dickerman JD; Erickson C; Finlay JL; Bozdech M; Hong R; Padilla-Nash H; Terasaki P
J Biol Response Mod; 1984 Aug; 3(4):406-12. PubMed ID: 6384432
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow determination of complement dependent and complement independent cellular cytotoxcity.
Orsini FR; Mihich E
Cell Immunol; 1975 Aug; 18(2):424-34. PubMed ID: 1095218
[No Abstract] [Full Text] [Related]
11. Efficacy of bone marrow purging in AML using monoclonal antibodies and complement.
Mills LE; Ball ED; Howell AL; Cornwell GG; Thompson L; Spruce W; Miller WE; McMillan R
Prog Clin Biol Res; 1990; 333():165-70. PubMed ID: 2308980
[No Abstract] [Full Text] [Related]
12. Elimination of clonogenic stem cells from human multiple myeloma cell lines by a plasma cell-reactive monoclonal antibody and complement.
Tong AW; Lee JC; Fay JW; Stone MJ
Blood; 1987 Nov; 70(5):1482-9. PubMed ID: 3663943
[TBL] [Abstract][Full Text] [Related]
13. Effects of monoclonal antibody and complement treatment of human marrow on hematopoiesis in continuous bone marrow culture.
Greenberger JS; Rothstein L; DeFabritiis P; Bregni M; Bast R; Ritz J; Nadler LM; Lipton JM; Sakakeeny MA
Cancer Res; 1985 Feb; 45(2):758-67. PubMed ID: 3967246
[TBL] [Abstract][Full Text] [Related]
14. Intracellular complement (complosome) is expressed in hematopoietic stem/progenitor cells (HSPCs) and regulates cell trafficking, metabolism and proliferation in an intracrine Nlrp3 inflammasome-dependent manner.
Ratajczak MZ; Adamiak M; Abdelbaset-Ismail A; Bujko K; Thapa A; Chumak V; Franczak S; Brzezniakiewicz-Janus K; Ratajczak J; Kucia M
Leukemia; 2023 Jun; 37(6):1401-1405. PubMed ID: 37055506
[No Abstract] [Full Text] [Related]
15. Eradication of neuroblastoma cells in vitro by monoclonal antibody and human complement: method for purging autologous bone marrow.
Saarinen UM; Coccia PF; Gerson SL; Pelley R; Cheung NK
Cancer Res; 1985 Nov; 45(11 Pt 2):5969-75. PubMed ID: 2414004
[TBL] [Abstract][Full Text] [Related]
16. Quantity and nature of residual bone marrow T cells after treatment of the marrow with Campath-1.
Irlé C; Kaestli M; Aapro M; Chapuis B; Jeannet M
Exp Hematol; 1987 Feb; 15(2):163-70. PubMed ID: 3545877
[TBL] [Abstract][Full Text] [Related]
17. Expression of Ia-like antigens defined by monoclonal OKIal antibody of hemopoietic progenitor cells in cord blood: a comparison with human bone marrow.
Koizumi S; Yamagami M; Miura M; Horita S; Sano M; Ikuta N; Taniguchi N
Blood; 1982 Oct; 60(4):1046-9. PubMed ID: 6956374
[TBL] [Abstract][Full Text] [Related]
18. Elimination of leukemic cells from human bone marrow using monoclonal antibody and complement.
Bast RC; Ritz J; Lipton JM; Feeney M; Sallan SE; Nathan DG; Schlossman SF
Cancer Res; 1983 Mar; 43(3):1389-94. PubMed ID: 6337707
[TBL] [Abstract][Full Text] [Related]
19. Comparative activities of rabbit complements of different ages using an in-vitro marrow purging model.
Roy DC; Felix M; Cannady WG; Cannistra S; Ritz J
Leuk Res; 1990; 14(5):407-16. PubMed ID: 2345466
[TBL] [Abstract][Full Text] [Related]
20. Complement depletion in vitro limits monoclonal antibody 6-19-dependent complement-mediated killing of tumor cells in bone marrow.
Duerst RE; Rose D; Frantz CN
Exp Hematol; 1991 Oct; 19(9):863-7. PubMed ID: 1893961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
